Engineered cardiac tissues (ECTs) serve as robust in vitro models to study human cardiac diseases including cardiac toxicity assays due to rapid structural and functional maturation and the ability to vary ECT composition. Metallothionein (MT) has been shown to be cardioprotective for environmental toxicants including heavy metals. To date, studies on the role of cardiomyocyte (CM)-specific MT expression and function have occurred in dissociated single cell assays or expensive in vivo small animal models. Therefore, we generated 3D ECTs using neonatal mouse ventricular cells from wild-type (WT) and the CM-specific overexpressing MT-transgenic (MT-TG) to determine the effect of MT overexpression on ECT maturation and function. Because Cadmium (Cd) is an environmentally prevalent heavy metal toxicant with direct negative impact on cardiac structure and function, we then determined the effect of MT overexpression to reduce Cd mediated CM toxicity within ECTs. We found: (1) structural and functional maturation was similar in WT and MT-TG ECTs; (2) Cd exposure negatively impacted ECT cell survival, maturation, and function; and (3) MT-ECTs showed reduced Cd toxicity as defined by reduced cleaved caspase 3, reduced Bax/Bcl2 ratio, reduced TdT-mediated dUTP nick-end labeling positive cells, reduced CM loss after Cd treatment, and delayed onset of cardiac dysfunction after Cd treatment. Thus, neonatal murine ECTs can serve as a robust in vitro model for heavy metal toxicity screening and as a platform to evaluate the role cardioprotective mechanisms, such as the MT-TG model, on environmentally relevant toxicants.
Over the past 2 decades, tissue engineering approaches, including the development of 3D cardiac tissue engineering paradigms, have proven to be a robust platform technology to test tissue repair paradigms and provide biotoxicity platform assays (Eschenhagen et al., 1997; Zimmermann et al., 2000; Tobita et al., 2006; Tiburcy et al., 2011; Nakane et al., 2017) . 3D engineered cardiac tissues (ECTs) have multiple advantages over traditional single cell or monolayer 2D culture methods including the formation of isotropic and aligned myocardial tissues that are electrically and mechanically and function similar to in vivo myocardium and the ability to customize cell composition to include multiple mesoderm lineages and/or genetically altered cells (Masumoto et al., 2016; de Lange et al., 2011) . ECTs are well suited for a variety of applications, including disease modeling (Katare et al., 2010; Song et al., 2011; de Lange et al., 2011; Hirt et al., 2012; Stö hr et al., 2013) , drug screening (Hansen et al., 2010) , and tissue repair (Zimmermann et al., 2006; Fujimoto et al., 2011; Masumoto et al., 2016; Nakane et al., 2017) . These ECTs can be formed use a range of 3D geometries including linear strips, rings, and porous patches. By varying 3D ECT geometry and size, 3D tissues can be generated for use in drug toxicity testing, to investigate 3D cell and tissue remodeling, and for tissue implantation for cardiac repair and regeneration. It is worth noting that cardiac cell isolation from neonatal murine hearts is technically more challenging than from neonatal rat, adult rodent, or larger vertebrate hearts, but then when isolated successfully these neonatal cells rapidly proliferate, remodel, and generate functioning myocardium.
Metallothionein (MT) is a small cysteine-rich protein that plays a key role in heavy metal detoxification, and cellular antioxidant defenses (Takahashi, 2015) . MT has also been shown to play an important role in regulating cell survival, apoptosis, and proliferation (Zhou et al., 2008) . Cardiac-specific human-MT2A transgenic (MT-TG) mice are derived from FVB wild type (WT) and have been characterized in our laboratory as an in vivo model to investigate the role of MT in cardioprotection (Gu et al., 2017; Kang et al., 1997; Zhou et al., 2008) . However, it is important to note that TG murine models are expensive to generate and maintain, and in vivo toxicology studies often require long in vivo exposure times. Conversely, isolated MT-TG cardiac cells can be used for in vitro toxicity assays but dissociated cells in culture do not always accurately reflect the response of functioning myocardium to metabolic and environmental stressors.
Cadmium (Cd) is an increasingly recognized to be an important environmental pollutant with negative cardiovascular (CV) bioeffects (Thevenod and Lee, 2013a,b) and because Cd does not degrade in the environment, the risk of human exposure to Cd is constantly increasing through food chain contamination. Therefore, Cd exposure is a serious global environmental and health problem. Chronic low dose Cd exposure has emerged as an underestimated and significant health hazard for at least 10% of the general population due to increased morbidity and mortality (Thevenod and Lee, 2015) . Prolonged exposure to cadmium causes various toxic effects in various organ systems, such as CV (Turdi et al., 2013; Tinkov et al., 2018) , kidneys (Satarug, 2018) , liver (Belhaj et al., 2018) , lung (Hutchinson et al., 2018) . Environmental Cd concentration is positively correlated with hypertension and arteriosclerotic heart disease mortality (Messner and Bernhard, 2010; Tellez-Plaza et al., 2013) . Cd may cause damage to the heart at exposures lower than required to damage other organs such as the liver and kidneys (Limaye et al., 1999) . Cd exposure has recently been shown to damage human iPSC-derived endothelial cells (Tang et al., 2017) .
As a nonessential metal ion, Cd competes with the biologically required metal ions to enter the cell, resulting in cell dysfunction and disease. Mechanistically, Cd toxicity is associated with various cellular, metabolic, homoeostatic and repair mechanisms, such as increased reactive oxygen species production and apoptosis (Nazimabashir et al., 2015) . Biochemical and physiological changes in the heart have been reported following Cd exposure, but the molecular elements involved in cadmium toxicity in CV disease have not yet been fully characterized. Therefore, the development and validation of robust in vitro models for detecting Cd-induced cardiomyocyte (CM) injury are likely to be useful in understanding the mechanism of Cdinduced cell changes in CM biology.
Here, we present data showing successful generation of ECT from cardiac cells derived from WT and MT-TG neonatal mouse hearts. We demonstrate that ECTs derived using MT-TG ventricular cells showed similar structural and functional characteristics to WT-ECT. We confirmed MT overexpression occurs in MT-ECT similar to MT whole heart. Additionally, we provide data that WT ECTs display clear toxicity to relatively brief Cd exposure and that MT-show reduced Cd toxicity. Thus, neonatal murine ECTs can serve as a robust in vitro model for heavy metal toxicity screening and as a platform to evaluate the role cardioprotective mechanisms, such as the MT-TG model, on environmentally relevant toxicants.
MATERIALS AND METHODS
Animals: neonatal WT and MT-TG mouse. Cardiac-specific MT-TG mice were produced from FVB WT mice obtained from Harlan Bioproducts for Science (Indianapolis, Indiana) as used in previous studies (Wang et al., 2006 Amino Acid(Sigma), 3 mmol/L sodium pyruvate (Gibco), 0.00384% (wt/vol) NaHCO3 (Sigma), and 1 mg/ml insulin (Sigma). Cell suspensions were preplated into sterilized tissue culture plates (100 Â 20 mm; Corning) and incubated at 37 C for 45 min to enrichment the CM population, followed by rotation at 50 rpm on a shaker (Labnet International) for an additional 4 h at 37 C and 5% CO 2 to facilitate CM cluster formation. Cardiac cells remaining in suspension were collected. Cells were stained with Trypan blue (Sigma), and the number of alive CMs was determined using a hemocytometer.
ECT construction and treatment. ECTs were constructed as previously described (Tobita et al., 2006; Fujimoto et al., 2011; de Lange et al., 2011; Ralphe et al., 2013; Masumoto et al., 2016) . Approximately 0.8 Â 106 CMs were suspended in 83.3 ml of mouse media and added to 116.7 ml of matrix mixture that consisted of 66.7 ml of 2 mg/ml acid-soluble rat-tail collagen type I (Sigma), 8. (Flexcell International) and incubated under preprogrammed vacuum conditions for 2 h (37 C, 5% CO 2 ) to form cylindrical ECT constructs. Following initial ECT gelation, 4 ml mouse medium/ECT was added in the 6-well culture dish. ECTs were maintained in culture medium for 7-14 days with media changes every other day. Some of ECTs were treated with either 20 mmol/l or 50 mmol/l CdCl2 for 24 h starting on day 6 (d6), using a protocol adapted from Cd exposure used in cell culture and in vivo (Limaye and Shaikh, 1999; Chen et al., 2015) .
Histology. ECTs were fixed in situ using 4% paraformaldehyde in 1ÂPBS (pH ¼ 7.2) at room temperature for 30 min then removed from the Tissue TrainTM plate and stored in PBS at 4 C (Masumoto et al., 2016) . Fixed ECTs were washed in 1% Triton-X-100/PBS for 1 hour at RT and then blocked with 1% Triton-X-100/ PBS þ 10% FBS for 1 hour at RT. Some sections were stained with hematoxylin and eosin. We stained nuclei with 4 0 ,6 0 -diamidino-2-Phenylindole, Dihydrochloride (DAPI) for 30 minutes and to stain CM we incubated with mouse anticTnT (1: 500 dilution; Thermo Fisher Scientific, Fremont, California). Some sections were also stained with mouse antiMT (1:500 dilution; Dako, Carpinteria, California). We randomly select 10 fields per ECT to count doublestained cTnT(Red) and DAPI(Blue) positive cells, and the cTnTþ/ DAPIþ percentage was used to determine the ratio of CM in ECTs.
Protein extraction and Western blotting. ECTs were washed thoroughly in ice cold PBS and rapidly homogenized in lysis buffer (100 ml/ECT) containing 50 mmol/l Tris-HCl (pH 7.4), 1ÂProtease inhibitor (Sigma), 1 mmol/l EDTA (pH 8.0), and 1 Â PMSF, and lysed in 4 C room for 4 h (Tobita et al., 2006) . After centrifugation at 12,000 rpm for 20 min, supernatants containing soluble WT, wild type mice; MT, metallothionein overexpressing transgenic mice.
proteins were subjected to protein concentration measurement using Bradford methods. Equal amounts of protein (15-30 mg) were resolved by SDS-Poylacrylamide Gel and transferred nitrocellulose membranes by blotting after blocking with 5% nonfat milk for 1h at room temperature, the membranes were incubated with primary antibodies. The primary antibodies included Cleaved Caspase3, Bax, Bcl-2 (1:1000 dilution; Cell Signaling Technology, Danvers, Massachusetts), followed by Anti-rabbit HRP-linked secondary antibody (1:5000 dilution; Cell Signal, Danvers, Massachusetts), and GAPDH (1:3000 dilution; Abcam, Cambridge, Massachusetts) as an internal control. MT expression was detected with a modified Western blot protocol as previously described using antibody against MT (1:1000 dilution; Dako, Carpinteria, California) (Wang et al., 2006) .
Protein expression levels were normalized to GAPDH as the internal control.
Isolation of RNA from ECT and quantitative real-time PCR. RNA extraction and quantitative real time PCR was performed as previously described in Nakane et al. (2017) and Ye et al. (2013) . Briefly, ECT samples were homogenized by an Omnitip Tissue homogenizer (USA Scientific, Ocala, Florida). Total RNAs were isolated using Invitrogen Trizol and purified by RNeasyMini Kit (Valencia, California). RNA quality and quantity were measured using the NanoDrop ND-1000 (Thermo Fisher Scientific, Waltham, Massachusetts) and the Bioanalyzer 2100 (Agilent Technologies Inc., Santa Clara, California). Equal amounts of RNA, 2 mg per sample, were used for the RT reaction to generate 
RESULTS

Basic Characteristics of WT-ECT and MT-ECT
ECTs started to contract spontaneously in a dyssynchronous manner on the second day after construction. ECTs initially beat faster and irregularly and then gradually transitioned to slower, synchronous beating by d5. Mouse ECT beating rate gradually declined during culture to d14 ( Figure 1A ) without noticeable or statistical difference between WT-and MT-ECTs. Typical for ECT gel compaction (Nakane et al., 2017) , we noted rapid gel compaction to d2 and then very gradual additional gel reduction to d14 without difference between WT-and MT-ECTs ( Figure 1B ). Also typical for linear ECTs, cell density was greater at the ECT edge compared with the ECT center ( Figure 1C ). Fluorescent staining of cTnT as a CM-specific marker showed greater concentration of CMs towards the edge and the bottom of ECTs ( Figs. 2A and 2B ). NonCMs appeared evenly distributed throughout the ECT. Therefore, MT overexpression had no significant impact on ECT beating rate, gel compaction, or ECT cellular distribution (Figs. 1 and 2 ).
MT Overexpression in MT-TG ECTs
The cardiac-specific MT-TG mouse is a well-established model to study the role of MT on cardiac protection (Gu et al., 2018; Xu et al., 2009 ). This study investigates the impact of cardiacspecific MT gene overexpression on neonatal murine ECT formation and maturation. Real-time qPCR assay showed significant MT2A gene expression in MT-ECT, comparable to MT2A gene expression in MT-TG mouse ventricle (MT-MV) ( Figure 3A) . Similarly, MT-ECT showed significantly higher MT protein content by Western blotting ( Figure 3B ) and IHC ( Figure 3C ), also comparable to MT-TG MV (Gu et al., 2017; Zhou et al., 2008) . Thus, the neonatal MT-ECT show comparably increased CMspecific MT expression.
CM Loss During ECT Culture
Next, we investigated whether overexpressed MT gene in CMs affects ECT's general features by comparing the basic features of ECT between WT-ECTs and MT-TG ECTs. Similar with other studies (Tiburcy et al., 2011) , we observed a progressive reduction in CM ratio during ECT culture from d0 to d14 ( Figure 4A ). The ratio of CMs to total cells in WT ECTs decreased from 27.3% 6 2.5% to 13.7% 6 1.5% from d7 to d14 (p < .05). MT overexpression has no impact on a similar gradual decline in CM within MT-ECTs from d7 to d14 ( Figure 4B ). We then examined if CM loss during in vitro culture is due to CM apoptosis, which has been noted to be low in embryonic chick and rat derived ECTs (Fujimoto et al., 2011) . Cleaved-caspase-3, a surrogate for apoptosis, was high and likely related to cell isolation mediated cell injury at cultured d0 and then significantly lower on d3 and d7 ( Figure 5A) . Surprisingly, low proapoptotic Bax ( Figure 5B ) and high antiapoptotic Bcl-2 ( Figure 5C ) protein levels were observed on d0, resulting in a decreased ratio of Bax/Bcl-2 on d0 ( Figure 5D ) that progressively increased on d3 and d7.
Molecular Evidence for Myocardial Maturation in ECT and Matrix
Remodeling During ECT Culture A hallmark of maturation in terminally differentiated CMs is the shift from fetal to adult CM alleles and gene expression profiles. As would be expected during CM maturation, we noted a shift from b-Myosin Heavy Chain (MHC) (fetal/slow) to a-MHC (mature/fast) expression in MV (Figs. 6A and 6B ). Interestingly, we noted a progressive decrease of b-MHC transcript expression ( Figure 6A ) but no significant increase in a-MHC transcript expression from d0 to d14 ( Figure 6B ). ECT maturation did result in a progressive increase in the ratio of a/b-MHC expression ( Figure 6C ). MT overexpression had no impact on the MHC isoform shift noted from d7 to d14.
We then examined matrix remodeling during ECT culture by measuring ECT total protein from d0 to d7, which showed that WT-ECT and MT-ECT ECT contained approximately 1000 mg protein ( Figure 7A ) on d0. We noted a dramatic reduction in total ECT protein by d3 and further reduction to a protein yield of approximately 150 mg from WT-ECTs and MT-ECTs ( Figure 7A ). Gel compaction ( Figure 1B ) and CM loss ( Figure 4B ) may partially explain the progressive reduction in total ECT protein content. Of note, MT overexpression did not affect total protein content within ECT at each time point ( Figure 7A ). As noted previously for h-iPSC derived ECTs (Nakane et al., 2017) , rapid murine ECT gel compaction and matrix remodeling occurred in the first 48 to 72 h after ECT formation, concurrent with initial ECT cell distribution and the onset of CM beating within each ECT ( Figure 1B) . Consistent with gel compaction (Figure 1B) , and an increase in non-CM during progressive in vitro culture ( Figure 4B ), we noted increasing type I and type III collagen content during both WT and MT ECT culture (Figs. 7B and 7C ) without a selective impact of MT overexpression on collagen expression.
MT Overexpression in ECT Protects From Cd-Induced ECT Injury
Due to the recognized negative biologic effects of Cd, including CM injury, we determined if Cd exposure adversely impacted murine ECT structure and/or function and if MT overexpression reduced Cd toxicity. We adapted a Cd exposure protocol used in cell culture and treated WT-ECT and MT-ECT with either 20 or 50 mmol/l for 24 h. We found that Cd caused a dose-dependent increase in myocardial apoptosis in ECTs indicated by increased cleaved caspase 3 and Bax/Bcl-2 ratio and that MT overexpression reduced Cd-induced caspase 3 ( Figure 8A ). Cd treatment (20 mmol/l Â 24 h) also induced cell death defined by increased TUNEL positive cell ratio ( Figure. 8B ) and lower cTnT positive cell ratio (Figs. 9A and 9B ). As hypothesized, MT overexpression reduced Cd-induced CM death with ECTs based on reduced caspase-3, Bax/Bcl-2 ratio, and Tunel positive ratio (Figure 8 ) and on reduced CM loss-based cardiac troponin T staining (Figure 9 ).
Cd treatment increased beating rate at þ24 h in WT ECTs (p ¼ .06), however, overexpression of MT blocked the effect of Cd on beating rate at þ24 h (p ¼ .99), resulting in a lower beating rate in MT ECT versus WT ECT (p < .01, Figure 10 ). We noted a progressively toxic effect of Cd treatment on ECT function (Table 1) . We defined Cd-induced changes in ECT function a global classification scheme: normal function (Nl); increased ECT deformation during shortening with regional dyssynchrony (A); increased ECT deformation during shortening with regional dyssynchrony (B); decreased beat rate with global dyssynchrony (C); and arrested beating (D). Representative videos of each Figure 5 . Apoptosis causes early cell death in ECTs. A, cleaved caspase-3 rapidly decreased from d0 to d7. B, Bax showed a trend to increase from d0 to d7 (p > .05) in WT ECT and increased from d0 to d7 in MT ECT. C, Bcl-2 decreased similar to cleaved caspase-3 from d0 to d7. D, Bax/Bcl-2 ratio increased from d0 to d7 (n ¼ 3-5 per group per time point), *p < .01 versus d0. No significant differences between WT and MT groups on the same day.
classification are available in the Supplementary Material. Cd treatment had a negative effect on ECT function starting at 8 h after treatment (Table 1 ) with a progressive shift from normal, synchronous beating to increased deformation with regional dyssynchrony followed by global dyssynchrony and sesation of beating by 72 h after treatment in WT ECT. MT overexpression had no effect on ECT function. MT overexpression delayed the onset of Cd-induced ECT dysfunction, shifting the first visible effects on ECT function to 24 h after treatment and delaying the onset of more significant changes in function to either 48 h after treatment (B) or 96 h after treatment (C, D). tein decreases rapidly during ECT culture from d0 to d7 similarly in WT and MTECTs (n ¼ 12 WT-ECT and n ¼ 9 MT-ECT at d0; n ¼ 3 WT-and MT-ECT at d3; and n ¼ 6 WT-ECT and n ¼ 5 MT-ECT at d7. *p < .01 versus d0. No significant differences between WT and MT groups on the same day. B, Collagen type I (Coll-I a1) transcript expression increased from d0 to d14 in WT and MT ECT groups (n ¼ 3-4 per group per time point), and decreased from P2 to adult in WT and MT MV (n ¼ 3-4 per group per time point). *p < .05 versus d0 ECT, #p < .05 versus d14 ECT. C, Collagen type III (Coll-III a1) transcript expression also increased from d0 to d14 in WT and MT ECT groups (n ¼ 3-4 per group per time point), and decreased from P2 to adult in WT and MT MV (n ¼ 3-4 per group per time point). *p < .01 versus d0 or P2, respectively. No significant differences between WT and MT groups on the same day. 
DISCUSSION
Using a traditional neonatal murine ECT in vitro model we noted that MT overexpression, confirmed by increased MT protein ( Figure 3A) , had no effect on ECT maturation as defined by beating rate, gel compaction, and cell distribution. While we had no a priori reason to suspect that MT overexpression would negatively impact ECT maturation or function, these data support the ability to use MT-ECTs as an in vitro model for myocardial toxicology and rescue where the injury pathway relates to heavy metals and/or oxidant stress. We noted the onset of synchronous beating, similar between WT and MT-ECTs, consistent with concurrent matrix consolidation and the reestablishment of myocardial cell coupling and electromechanical wave propagation as has been recently summarized (Weinberger et al., 2017) . We noted a progressive decrease in ECT total protein content consistent cell loss and with ECT matrix metabolism and remodeling and a progressive increase in the content of collagens I and III consistent with myofibroblast ECT remodeling ( Figure 7 ) as has been previously described by Zimmerman and colleagues (Lockhart et al., 2011) . MT overexpression did not alter this trend in total protein reduction or increasing collagen content. We noted a gradual decline in ECT cellularity as well as a gradual decline in CM percentage defined by cTnT/DAPI ratio (Figure 4) . Cell loss during early ECT maturation is likely due to cell injury at isolation and cell death, with high C-caspase 3 and pro-apoptotic Bcl-2 on d0 that rapidly decrease by d3 Zhang et al. (2001) . The increasing ratio of Bax/Bcl-2 from days 3 to 7 ( Figure 5D ) is consistent with our previous data on low caspase 3 at d14 in embryonic rat ECT (Fujimoto et al., 2011) . The low proapoptotic Bax ( Figure 5B ) and high antiapoptotic Bcl-2 ( Figure 5C ) protein levels observed on d0 that progressively increased on d3 and d7 suggest a role for a non-mitochondrial apoptotic pathway. Caspase-8 has not been studied in ECTs and there is a single report of apoptosis inducingfactor, AIF, in rat ECTs. (Leontyev et al., 2013) . These additioinal mediators of cell death may also be involved in ECT cell death and should be included in future experiments.
ECT maturation was further supported by a typical myosin isoform shift with a progressive reduction in b-MHC (fetal/slow) and increase in the ratio of a-MHC (mature/fast) to b-MHC expression, similar to the transition pattern from neonatal to adult MV (Figure 6 ) and consistent with increased twitch velocity and force noted during neonatal murine ECT maturation (de Lange et al., 2011) . Of note, MT overexpression did not impact this myosin isoform shift. Finally, we noted ECT matrix maturation with increased collagens I and III content which was unaffected by MT overexpression. These data support the use of WT and MT-ECTs as 3D tissue surrogate models to assess CM injury and remodeling.
This study also explores Cd toxicity in both WT and MTECTs to validate the sensitivity of the 3D tissue surrogate ECT model to detect CM injury following Cd exposure and to determine if MT overexpression provides a protective effect as has been noted for MT overexpression in vivo (Gu et al., 2017 (Gu et al., , 2018 Wang et al., 2006; Xu et al., 2009; Zhou et al., 2008) . Our new data confirm that Cd exposure negatively impacts immature CM survival in both WT and MT-ECTs, consistent with Cd mediated toxicity. The induction of CM apoptosis by exposure to Cd has been described (Alpsoy et al., 2014) and our data confirm that Cd induces CM apoptosis in ECTs. Although metal chelation therapy is the most effective means for the treatment of metal Data shown as mean 6 SD.
intoxication (Freisinger and Vasak, 2013) , Cd can form complexes with MT and the resulting Cd-MT complex likely provides cell and tissue protection, as we have noted based on reduced ECT cell death (Figure 8 ). Our observation of impaired function following Cd treatment (Table 1) is consistent with epidemiologic studies showing that Cd exposure has a positive relationship with frontal T-wave axis deviation, a subclinical marker of ventricular arrhythmias (Faramawi et al., 2012) . Cd treatment-induced blockade of L-type calcium channels (Shen et al., 2000) , altered outward potassium current (Follmer et al., 1992) and disturbed sodium transport (DiFrancesco et al., 1985) might explain the impaired function noted in Cd-treated ECTs. Thus, functional abnormalities in beating rate and synchrony observed in Cd treated ECTs may serve as a surrogate for arrhythmia, as has been noted in other ECT models of myocardial dysfunction associated with cardiomyopathies (Stillitano et al., 2016; Smelter et al., 2018) or drug exposure (Eder et al., 2014; Lee et al., 2017; Smith et al., 2017) .
Further studies are required to identify the molecular mechanisms by which Cd treatment alters CM survival and function within neonatal murine ECTs and how MT overexpression reduces Cd toxicity. Our data support the paradigm that neonatal murine ECTs can serve as a robust in vitro surrogate model for the in vivo myocardium, allowing a more cost effective and scalable strategy for identifying myocardial toxicity and preventive strategies. These results can then be translated to more expensive small and large animal preclinical models for further validation.
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences online. ECT function following Cd exposure was digitally recorded for 15 s at 8, 24, 48, 72, and 96 h starting at the time of Cd treatment on d6. ECT function was then qualitatively classified as: normal function (Nl); increased ECT deformation during shortening with regional dyssynchrony (A); increased ECT deformation during shortening with regional dyssynchrony (B); decreased beat rate with global dyssynchrony (C); and arrested beating (D). Group sizes ranged from n ¼ 3-8. WT ECTs displayed dysfunction 8 hrs after 20 mM Cd exposure with progressive dysfunction resulting in absent contractions by 72 h after exposure. MT over-expression delayed the onset of 20 mM Cd exposure-induced ECT dysfunction to 24 h after exposure and this protective effect persisted up to 96 h after Cd exposure.
